INMD PEER ANALYSIS

InMode Ltd — metric-by-metric comparison with peers and the industry median

INMDInMode Ltd

🇺🇸 USA · NASDAQ · Healthcare · Medical Devices

Value itDuel

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial Health
INMDIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
INMD-2.7%4DX+1,670.8%SN+4.2%COH-57.7%ONCSM+203.3%MEDTR-8.2%
Year-to-Date (YTD)
INMD+0.7%4DX+8.1%SN-7.6%COH-51.5%ONCSM-4.8%MEDTR+0.3%

Key Metric Comparison

P/E

Lower is better
INMD10.854DXSN20.56COH23.72ONCSM122.41MEDTR596.83Median 27.44

ROE

Higher is better
INMD13.6%4DXSN12.1%COH18.1%ONCSM12.9%MEDTR0.2%Median -8.6%

Net Margin

Higher is better
INMD23.3%4DX-3,684.6%SN10.1%COH14.6%ONCSM6.3%MEDTR0.2%Median -5.7%

Revenue Growth

Higher is better
INMD-4.5%4DX-26.0%SNCOH2.0%ONCSM39.1%MEDTR6.5%Median 7.4%

All Metrics

Valuation
MetricINMD4DXSNCOHONCSMMEDTRInd. Median
P/E10.8520.5623.72122.41596.8327.44
P/B1.43-74.162.484.2313.361.082.48
EV/EBITDA4.029.8814.8725.4610.9315.23
P/S2.53243.162.093.477.661.182.66
Financial Health
MetricINMD4DXSNCOHONCSMMEDTRInd. Median
Current Ratio8.806.572.572.462.253.583.28
Debt/Equity0.7%-22.6%62.9%22.1%35.0%1.0%44.7%
NetDebt/EBITDA-5.170.711.720.420.42-1.640.82
Profitability
MetricINMD4DXSNCOHONCSMMEDTRInd. Median
Net Margin23.3%-3,684.6%10.1%14.6%6.3%0.2%-5.7%
ROE13.6%12.1%18.1%12.9%0.2%-8.6%
ROA12.0%-264.3%6.1%12.4%8.0%0.2%-6.4%
EBITDA Margin27.5%-818.8%25.6%24.0%30.6%9.4%5.2%
Growth + Dividend
MetricINMD4DXSNCOHONCSMMEDTRInd. Median
Rev. Growth-4.5%-26.0%2.0%39.1%6.5%7.4%
NI Growth-50.4%-6.8%-62.9%16.7%
Div. Yield3.5%3.6%0.0%1.1%1.1%
Payout52.8%81.5%0.0%656.3%39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on INMD

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.